Top Markets
Coin of the day
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.

American Oriental Bioengineering, Inc.

AOBI
Clasificación en acciones #42790
American Oriental Bioengineering, Inc. (AOBI), headquartered in Beijing, China,... American Oriental Bioengineering, Inc. (AOBI), headquartered in Beijing, China, focuses its operations on the development, manufacturing, and commercialization of a broad spectrum of pharmaceutical and healthcare products. The company's core pharmaceutical offerings include a range of prescription medications. Among these are the Shuanghuanglian Lyophilized Injection Powder (SHL brand), prescribed to treat flu symptoms such as elevated fever, coughs, and sore throats, as well as to address upper respiratory tract infections, mild pneumonia, bronchitis, and tonsillitis. Another significant prescription product is the Cease Enuresis Soft Gel (CE Gel brand), formulated to alleviate bedwetting. AOBI's portfolio also extends to various over-the-counter (OTC) pharmaceutical solutions. These feature the Cease Enuresis Patch for managing bedwetting and urinary incontinence; Jinji Capsule, used for conditions like endometritis, annexitis, and pelvic inflammations; Jinji Yimucao, designed to relieve premenstrual syndrome (PMS) and other related menstrual and menopausal discomforts; and Boke Nasal Spray, which offers relief for sinus congestion associated with the common cold, nasal stuffiness, chronic rhinitis, allergic rhinitis, and nasosinusitis. Furthermore, the company develops and markets a selection of nutraceutical products, notably including soybean peptide-based items available as beverages, tablets, powders, and instant coffee. Beyond its manufacturing activities, AOBI is also involved in the wholesale and retail distribution of both its pharmaceutical and nutraceutical goods. The company's products are sold across the People's Republic of China through both direct channels and a network of distributors, reaching hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical retailers, and various other retail outlets.
Precio por acción
$0.0012
Última sincronización: 2026-08-11
Capitalización bursátil
$88.00
Cambio (1 día)
0.00%
Cambio (1 año)
140.00%
País
CN
Comercio American Oriental Bioengineering, Inc. (AOBI)

Categoría

Precio AOBI con Capital del mercado a B
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.
AOBI
$0.0012
Capitalización de mercado de American Oriental Bioengineering, Inc.(AOBI)
Capitalización bursátil: $88.00
A fecha de August 2026, American Oriental Bioengineering, Inc. tiene una capitalización de mercado de $88.00. Esto convierte a American Oriental Bioengineering, Inc. en la 42790th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de American Oriental Bioengineering, Inc. desde 2001 hasta 2026
AOBI en comparación con los más populares 5 títulos stocks
Precio por AOBI Activo B Capital del mercado en B Resultados
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.
$73,991,089 $88.00
$5.426T +6,165,924,076,240.12%
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.
$60,503,503 $88.00
$4.437T +5,041,958,570,211.68%
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.
$56,557,148 $88.00
$4.148T +4,713,095,675,883.76%
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.
$49,961,690 $88.00
$3.664T +4,163,474,181,032.64%
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.
$39,399,036 $88.00
$2.889T +3,283,252,979,459.00%